Beyond the genome: Molecular imaging in vivo with PET and SPECT

Academic Radiology

Volumn 8, Issue 1, 2001, Pages 4-14

  Luker, Gary D ^a   Piwnica Worms, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; DNA; GLYCOPROTEIN P; HEXOKINASE; IODINE 131; MESSENGER RNA; PENTETATE INDIUM IN 113M; SODIUM IODIDE; TECHNETIUM 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CONFERENCE PAPER; GENE EXPRESSION; GENOME; IMAGING; MEDICAL SOCIETY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPORTER GENE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; REVIEW;

ANIMALS; GENES, REPORTER; GENOME, HUMAN; HUMANS; MOLECULAR BIOLOGY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034917741     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(03)80738-9     Document Type: Conference Paper

References (91)

1. Human genome: Finally, the book of life and instructions for navigating it
2. Somatostatin receptor scintigraphy with [in-111-DTPA-D-Phe] and [1123-Tyr]octreotide: The Rotterdam experience with more than 1000 patients
3. Pre-clinical evaluation of technetium-99m platelet receptor-binding peptide
4. Which nodular goiters should be removed?
5. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: An overview of different analytical methods
6. Iodide transport in the thyroid gland
7. The mammary gland iodide transporter is expressed during lactation and in breast cancer
8. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy
9. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
10. Isolation and expression of a complementary DNA that confers multidrug resistance
11. Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification
12. Biochemistry of multidrug resistance mediated by the multidrug transporter
13. P-glycoprotein multidrug resistance and cancer
14. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
15. Tissue distribution of multidrug resistance protein
16. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2
17. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene
18. Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
19. A multidrug resistance transporter from human MCF-7 breast cancer cells
20. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
21. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance
22. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer drugs
23. Pharmacology of drugs that alter multidrug resistance in cancer
24. PSC 833 a non-immunosuppressive cyclosporin analog, is a very potent multidrug-resistance modifier
25. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
26. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979
27. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209, and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP
28. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C
29. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance
30. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1
31. Transfer and expression of the human multiple drug resistance gene into live mice
32. Resistance to taxol chemotherapy produced in mouse marrow cells by safety-modified retroviruses containing a human MDR-1 transcription unit
33. Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy
34. Functional identification of multidrug resistance gene expression in vivo
35. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex
36. Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation
37. 99mTc-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: In vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant
38. Differences between accumulation of Tc-99m-MIBI and TI-201 -thallous chloride in tumor cells: Role of P-glycoprotein
39. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: Correlation with mdr gene expression
40. In vivo detection of multidrug resistance (MDR1) phenotype by technetium-99m-sestamibi scan in untreated breast cancer patients
41. Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients
42. Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m-sestamibi
43. Modulation of the multidrug resistance P-glycoprotein: Detection with Tc-99m-sestamibi in vivo
44. Dipyridamole modulated Tc-99m-sestamibi (mibi) scintigraphy: A predictor of response to chemotherapy in patients with small cell lung cancer
45. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors
46. Characterization of P-glycoprotein transport and inhibition in vivo
47. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer
48. Tumor clearance of technetium-99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer
49. Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug resistance P-glycoprotein
50. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: In vitro studies in multidrug-resistant breast tumor cells
51. Characterization of phosphine complexes of technetium (III) as transport substrates of the multidrug resistance (MDR1) P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier
52. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors
53. Novel Tc(III)-Q-complexes for functional imaging of the multidrug resistance (MDR1) P-glycoprotein
54. Metal complexes for therapy and diagnosis of drug resistance
55. Effects of MDR1 and MDR3 P-glycoproteins, MRP1 and BCRP/MXR/ ABCP on transport of Tc-99m-tetrofosmin
56. Visualization of multidrug resistance in vivo
57. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: Potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo
58. Uptake and retention of hexakis (2-methoxy isobutyl isonitrile) technetium(I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence
59. Imaging gene expression in cancer: Functional identification of multidrug resistance (MDR1) P-glycoprotein in vivo
60. High-resolution microPET imaging of carcinoembryonic antigen-positive xenograffs by using a copper-64-labeled engineered antibody fragment
61. 99mTc-labeled small peptides as diagnostic radio-pharmaceuticals
62. Cell internalization of the third helix of the antennapedia homeodomain is receptor-independent
63. Intercellular trafficking and protein delivery by a herpesvirus structural protein
64. Functional similarity of HIV-1 rev and HTLV-1 rex proteins: Identification of a new nucleolar-targeting signal in rev protein
65. Cellular uptake of the tat protein from human immunodeficiency virus
66. Tat-mediated delivery of heterologous proteins into cells
67. Transduction of full-length TAT fusion proteins directly into mammalian cells: TAT-p27Kip1 induces cell migration
68. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus
69. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates
70. Synthesis and characterization in vitro of membrane permeant peptide conjugates for imaging and radiotherapy
71. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy
72. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein
73. In vivo protein transduction: Delivery of a biologically active protein into the mouse
74. Progress toward in vivo imaging of reporter gene expression using positron emission tomography
75. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with Tc-99m or Re-188
76. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals
77. Quantification of target gene expression by imaging reporter gene expression in living animals
78. Monitoring gene therapy with cytosine deaminase: In vitro studies using tritiated-5-fluorocytosine
79. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: Early kinetics of radiolabelled FIAU
80. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug
81. Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: Autoradiographic assessment in an animal model
82. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy
83. Assays for noninvasive imaging of reporter gene expression
84. Performance evaluation of microPET: A high-resolution lutetium oxyorthosilicate PET scanner for animal imaging
85. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
86. Simultaneous PET and MR imaging
87. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy
88. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography
89. Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: Implications for noninvasive imaging of transgene expression
90. Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomography
91. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo